ZEVASKYN ® (prademagene zamikeracel) is an autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback